Albert Bourla, CEO of Pfizer, said during the G20 Global Health Summit Friday that the company will provide 2 billion doses of its Covid-19 vaccine to lower and middle-income countries over the next 18 months.
“Today, Pfizer and BioNTech are pledging to provide two billion doses of our Covid-19 vaccine to middle- and low-income countries over the next 18 months,” Bourla said. “We expect to provide a billion of these doses to low- and middle-income countries this year, and we pledge to deliver another billion doses to these countries in 2022.”
Bourla said he hopes this will accelerate the ability to save even more lives globally.
Bourla told Axios on Wednesday that Pfizer plans to produce 6 billion doses of its Covid-19 vaccine over the next 18 months.